ExamPat

Sharon L Turner

USPTO Patent Examiner·Active 2012 to 2023

Sharon L Turner is a USPTO patent examiner who has handled 55 ex parte reexaminations between 2012 and 2023. These reexams concentrate in Chemistry & Materials, Life Sciences & Consumer, and Physics & Instruments. ExamPat indexes the full prosecution record for each of these cases, including office-action grounds, certificate outcomes, and downstream PTAB and federal-circuit decisions.

Filings by year

6
12
4
13
5
14
9
15
5
16
3
17
3
18
6
19
4
20
3
21
4
22
3
23

Technology mix

Chemistry & Materials43 (78%)
Life Sciences & Consumer8 (15%)
Physics & Instruments3 (5%)
Mechanical & Manufacturing1 (2%)

Compare against all examiners

Eight side-by-side metrics: case volume, pendency, OAs per reexam, rejection mix, SNQ denial rate, certification rate, and PTAB appeal rate, with a Δ column showing where this examiner runs higher or lower than the corpus.

  • Average and median pendency, both for this examiner and the corpus
  • Rejection basis split (102 / 103 / 112) head-to-head
  • Certification, SNQ denial, and PTAB appeal rates

Certificate outcome distribution

How this examiner's certificates split across the six possible outcomes: all claims confirmed, confirmed with amendment, confirmed with new claims, mixed, or all claims canceled. Includes share comparison to the corpus distribution.

  • Count and share for each of the six outcome buckets
  • Δ vs. corpus distribution in percentage points
  • Useful for setting realistic patent-owner expectations

Event-to-event timing

Median time for this examiner's cases at each prosecution stage — filing to first office action, filing to NIRC, and filing to certificate — with corpus comparison and sample size.

  • Median in months per transition
  • Side-by-side with the corpus median
  • n column showing how many of this examiner's cases completed each transition

Recent reexaminations (showing 25 of 55)

Control #FiledPatentTitlePendencyStatus
90/019,321Dec 5, 20238,609,935SOYBEAN EVENT DP-305423-1 AND COMPOSITIONS AND METHODS FOR THE IDENTIFICATION AND/OR DETECTION THEREOF15 moClosed
90/019,319Dec 1, 20237,838,733NOVEL HERBICIDE RESISTANCE GENES17 moClosed
90/019,229Jul 19, 202310,463,049ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA15 moClosed
90/019,139Dec 9, 20229,695,439METHODS FOR GENETIC CONTROL OF INSECT INFESTATIONS IN PLANTS AND COMPOSITIONS THEREOF13 moClosed
90/019,138Dec 4, 20227,632,985SOYBEAN EVENT MON89788 AND METHODS FOR DETECTION THEREOF13 moClosed
90/019,131Nov 18, 20228,283,522NOVEL HERBICIDE RESISTANCE GENES28 moClosed
90/015,055Jun 24, 20228,465,937METHODS FOR IDENTIFYING B-CLONES WHICH BIND CELL-SURFACE ANTIGENS15 moClosed
90/014,907Nov 19, 20219,783,791Mutant Reverse Transcriptase and Methods of Use—Closed
90/014,882Oct 15, 202110,774,309Natural killer cell immunotherapy for treating cancer17 moClosed
90/014,681Feb 16, 202110,920,222TREATING AND PREVENTING MICROBIAL INFECTIONS7 moClosed
90/014,582Sep 21, 202010,179,938ARTIFICIAL SELECTION METHOD AND REAGENTS39 moClosed
90/014,573Sep 15, 20208,999,291Compositions and Methods for the Removal of Biofilms18 moClosed
90/014,448Feb 11, 202010,464,992VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION59 moClosed
90/014,428Jan 2, 20209,550,834Methods for Preparing Glycan-Hydrolyzed Antibody, and Homogeneous Glycosylated Antibody14 moClosed
90/014,394Oct 23, 20199,675,668Modified Polynucleotides Encoding Hepatitis A Virus Cellular Receptor 232 moClosed
90/014,365Aug 12, 20199,534,234ENHANCED NUCLEIC ACID CONSTRUCTS FOR EUKARYOTIC GENE EXPRESSION54 moClosed
90/014,353Aug 2, 20199,511,092CHIMERIC RECEPTOR WITH NKG2D SPECIFICITY FOR USE IN CELL THERAPY AGAINST CANCER AND INFECTIOUS DISEASE13 moClosed
90/014,319Jun 19, 20199,580,697ENHANCED NUCLEIC ACID CONSTRUCTS FOR EUKARYOTIC GENE EXPRESSION15 moClosed
90/014,296May 1, 20199,567,577Expression Vector Comprising A Polynucleotide Encoding A Modified Glutamine Synthetase And A Method For Preparing A Target Protein Employing the Same11 moClosed
90/014,290Apr 19, 20199,926,574WIDESPREAD GENE DELIVERY TO MOTOR NEURONS USING PERIPHERAL INJECTION OF AAV VECTORS11 moClosed
90/014,175Aug 1, 20189,511,092CHIMERIC RECEPTOR WITH NKG2D SPECIFICITY FOR USE IN CELL THERAPY AGAINST CANCER AND INFECTIOUS DISEASE49 moClosed
90/014,159Jun 29, 20188,703,485GERM CELLS HAVING INACTIVATED ENDOGENEOUS IMMUNOGLOBULIN GENES, AND TRANSGENIC ANIMALS DERIVED THEREFROM7 moClosed
90/014,063Jan 10, 20188,314,225HEAVY CHAIN MUTANT LEADING TO IMPROVED IMMUNOGLOBULIN PRODUCTION50 moClosed
90/014,017Sep 29, 20179,040,052Precision Medicine by Targeting Rare Human PCSK9 Variants for Cholesterol Treatment26 moClosed
90/013,979Jul 10, 20178,951,523Targeting Rare Human PCSK9 Variants for Cholesterol Treatment19 moClosed

Other USPTO reexam examiners

Get the full reexam analytics

Compare Sharon L Turner against the full corpus, see the certificate-outcome split, drill into event timing, filter the case list, and export. Free to sign up.